Americas Gold Nanoparticles Market Flourishes Relentlessly; Asserts MRFR Unleashing Industry Forecast Up To 2027

Americas Gold Nanoparticles Market - Overview

Nano therapy is a modern technique for treatment of various diseases and performed with the help of submicron sized molecular devices or nanoparticles. According to the National Cancer Institute (2014), over 16 lakh Americans had cancer, which is expected to increase during the given period. Increasing prevalence of diseases such as diabetes and cancer, rising demand for the better treatment options, and increasing healthcare expenditure drives the growth of the market. According to the International Diabetes Federation, about 420 million adult population in the world was suffering from diabetes in 2016, which is increasing at the rate of 8.4% per year and is expected to reach 625 million by 2040.

 Furthermore, the government support for research and continuous improvement in healthcare infrastructure boost the market growth. However, higher cost of the treatment and strict regulatory norms may slow the growth of the Americas gold nanoparticles market over the forecast period.

According to a recent study report published by the Market Research Future, the Americas Gold Nanoparticles market is booming, and expected to gain prominence over the forecast period growing rapidly .The market is expected to demonstrate a spectacular growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2027).  

Americas Gold Nanoparticles Market - Competitive Analysis

Cytodiagnostics (U.S.), NanoHybrids Corp (U.S.), BBI Solutions (U.S.), NanoSphere, Inc. (U.S.), Smith and Nephew (U.K), Selecta Biosciences, Inc. (U.S.), Sirnaomics, Inc. (U.S.), Tarveda Therapeutics (U.S.), Nanobiotix (France), Nanoprobes, Inc. (U.S.), Nanosphere Inc. (U.S.), NanoMedia Solutions Inc. (Japan), NanoBio Corporation (U.S.), NanoBioMagnetics (U.S.) are some of the prominent players at the forefront of competition in the Americas gold nanoparticles market and are profiled in MRFR Analysis. 

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Cytodiagnostics

Based in Burlington, Ontario, Canada, Cytodiagnostics is a biotechnology company with focus of developing nanotechnology derived products and services for the international life science and material science markets. Gold and silver nanoparticles, magnetic nanoparticles, and polystyrene beads are three major segments of the company.

• Under Gold Nanoparticles, the company offers wide range of products such as spherical gold nanoparticles, gold nanourchins, gold nanorods, gold nanoparticle conjugation, gold conjugates, functionalized and pegylated gold nanoparticles, organic soluble gold nanoparticles, gold nanoparticle size optimization panels, and gold nanoparticles for flow cytometry.

NanoHybrids Corp

Based in Austin, U.S., NanoHybrids develops nanoparticle contrast agents having wide range of applications in molecular diagnostic, photoacoustics, optical imaging and microscopy.

• Gold NanoRods and Gold NanoSpheres are two major products offered by the company.

BBI Solutions

Headquartered in the US, BBI Solutions is a leading developer and manufacturer of raw materials and finished test platforms for the in-vitro diagnostics market. The company manufactures the gold nanoparticles used in the treatment of the different diseases for instance, cancer and cardiovascular diseases.

Luminex Corporation

Headquartered in Canada, Luminex Corporation manufactures and markets the proprietary biological testing technologies with the applications in life-sciences.

• Verigene is one of the major products of the company that uses the nanogrid technology.

Americas Gold Nanoparticles Market   -

Regional Analysis

North America dominates the Americas gold nanoparticles market owing to increasing prevalence of cancer and other chronic diseases, well-developed healthcare sector, and growing demand for the better treatment. North America is segmented into two regions: the U.S. and Canada. The U.S. accounts for the major share in the market owing to the high healthcare spending and increasing government support for research & development. South America is the fastest growing market due to the presence of huge opportunities for the development of the market. According to the American Diabetic Association (2012), 29 million Americans had diabetes, which was 9.3% of the total American population and as per the National Cancer Institute (2016), about 1,685,210 new cases of cancer had been diagnosed in the U.S. In Canada, the market for gold nanoparticles shows significant growth owing to the rising awareness about the nanotechnology and extensive research in the field of nanotechnology. In South America, the market exhibits steady but positive growth owing to an increasing emphasis on preventive care and growth of healthcare industry. On the other hand, the higher cost of treatment and lack of awareness about treatment may hinder the growth of the Americas gold nanoparticles market.

Browse Full Report @ https://www.marketresearchfuture.com/reports/americas-gold-nanoparticles-market-1129 .